Objective: Non-surgical treatment can be effective for many musculoskeletal conditions. Improving access to these options may improve the efficiency of hospitals. The Orthopaedic Physiotherapy Screening Clinic and Multidisciplinary Service offers early comprehensive assessment and coordinated, patient-centred care within a multidisciplinary framework. Our aim was to assess its cost-effectiveness compared with usual orthopaedic care.
Introduction
Given increasingly scarce health resources and the emergence of new models of care designed to improve both patient flow and the distribution of health resources to those most in need, cost-effectiveness evaluation of new services is required. In Australia, health care for arthritis and musculoskeletal conditions cost $4.0 billion in 2004-05. 1 These costs are rising partly due to increasing prevalence of these conditions but also because of increasing reliance on expensive surgical options for their management at younger ages. 2 There is, therefore, increased need for economic evaluation of programs to manage these conditions. [3] [4] [5] Up to 80% of patients referred to orthopaedic outpatient services can be managed without surgery. 6 Some orthopaedic outpatient services have therefore been re-designed to increase the availability of non-surgical options. 7, 8 The Orthopaedic Physiotherapy Screening Clinic and Multidisciplinary Service (OPSC & MDS) is one such initiative, offering early expert assessment and comprehensive, coordinated, patientcentred care within a multidisciplinary framework. 9 The OPSC & MDS has been implemented in most orthopaedic services in Queensland public hospitals.
The OPSC & MDS is led by experienced musculoskeletal physiotherapists working in an advanced practice role. They undertake initial assessment, diagnosis, management planning and case management. They also lead and provide consultancy for a designated multidisciplinary team who provide follow-up treatment.
Employing experienced physiotherapists in advanced roles in hospital specialist outpatient services has been successfully implemented in the UK [10] [11] [12] and in other Australian states. [13] [14] [15] A particular focus of these services is to reduce waiting times for patients unlikely to require surgery. There is evidence that extended waiting times are detrimental to quality of life, [16] [17] [18] physical and psychological wellbeing, expected benefits of surgery [19] [20] [21] and have significant economic consequences. [22] [23] [24] Although many examples of service re-design exist, little has been achieved in providing a comprehensive economic evaluation of the impact of introducing these services. In orthopaedics, the only two studies that have assessed non-surgical models of care 25, 26 found they could result in cost savings to the health system though neither used a cost-utility approach. Brown et al., 25 who compared a musculoskeletal physician and orthopaedic surgeon-led service, found similar outcomes at 12 months with lower cost for the musculoskeletal physician group, driven mainly by reduced surgical costs. Daker-White et al. 26 compared the outcomes and costs for patients referred to a hospital outpatient orthopaedic department treated by either specially trained physiotherapists or junior orthopaedic surgeons. No clinically important differences were found between the two groups though physiotherapists were less likely to order investigations and refer patients for surgery, resulting in lower direct hospital costs. Our aim was to assess the costs, health outcomes, value for money and potential for cost-savings of OPSC & MDS compared with usual orthopaedic care from the perspective of the health care payer.
Methods

Model structure
A Markov model with nine health states was constructed in TreeAge Pro 2013 Õ to estimate the quality-adjusted life years gained (QALYs) and health care costs from the perspective of the health payer (Queensland Government). (An overview of the health states in the Markov model and the possible transitions between each health state is provided in the Supplementary material, available online). Patients with low back, knee or shoulder conditions considered to be unlikely to require surgery were included in the model as these are the three most frequently treated conditions and represent approximately 75% of patients seen by the OPSC & MDS service. Clinical pathways for orthopaedic outpatients were identified for usual care and OPSC & MDS in consultation with an expert working group of clinicians and managers convened for the project. These pathways formed the basis of the Markov model. The time frame for the model was five years. Costs and benefits were discounted at 5% per year, a commonly used discount rate in economic evaluations. 27 A series of assumptions are made in the model:
. Death rate is calculated from the Australian Life Tables and represents death from all causes. . Transitions from the waiting list states are modelled using a tunnel state where individuals remain in that state for a certain number of cycles before moving into other states. This is to represent the minimum time people will have to wait for before any possibility of an appointment. . The perspective of the costs analysis is limited to that of the health care system. This does not factor in substantial costs which can be incurred by individuals on waiting lists due to impacts on income or other medical expenses.
Usual Care pathway
Referrals for an orthopaedic consultation are triaged by clinical staff according to the written referral as categories 1 (urgent), 2 (semi-urgent) and 3 (non-urgent) and entered onto a waiting list for an initial consultation ( Figure 1 ). In Queensland public hospitals, target waiting times to be seen for an initial consultation are <30 days for category 1, <3 months for category 2 and <12 months for category 3; however, many patients wait longer than these targets. 28 Following the initial consultation the patient may be: returned for continuing management by their general practitioner; referred to conservative management which could include physiotherapy or other medical management such as injections; placed on a surgical wait list; or continue to be monitored for the need for surgery and called back for review at a later date.
OPSC and MDS pathway
Potentially eligible patient referrals are screened by a musculoskeletal physiotherapist (OPSC & MDS Clinical Leader) when received by the orthopaedic outpatient service ( Figure 2 ). Patients are referred to the OPSC & MDS if they have been triaged to be category 2 or 3, have benign musculoskeletal conditions where serious pathology is not suspected and immediate surgery is not indicated and are considered as likely to benefit from non-surgical management.
Compared to Usual Care where patients commonly wait about 18 months for category 2 and about three years for category 3, 29 the initial waiting time of the OPSC & MDS pathway is considerably less with patients generally seen within one month of referral.
Patients within the OPSC & MDS are given a one-hour initial screening assessment with a physiotherapist who has postgraduate qualifications in musculoskeletal physiotherapy (in addition to the usual four year Bachelor degree). These clinicians typically have more than 10 years experience in the management of patients with musculoskeletal conditions, have undertaken additional targeted professional development and have developed an extensive breadth and depth of clinical consultancy in the management of patients with chronic and complex musculoskeletal conditions. Following the OPSC & MDS initial screening the patient may be referred for co-ordinated multidisciplinary non-surgical management provided within the service. This can include physiotherapy, occupational therapy, dietetics, psychology and pharmacy as well as other allied health intervention when indicated (e.g. podiatry). In addition to services tailored to individual patients, group-based programs are used to support ongoing self-management, knowledge and skill development. Alternatively, following screening the patient may be referred back to the orthopaedic specialist waiting list. This may occur if issues are identified that indicate the need for urgent medical attention or suggest a strong need for surgical review. Depending on the urgency of the presentation, the patients' waiting time until medical specialist review may be fast-tracked during this process via recommendation from the OPSC & MDS clinician. Although this process may not require further input from the OPSC & MDS, the initial screening by the musculoskeletal physiotherapist will have resulted in earlier identification and specialist consultation for those patients whose conditions are not benign or who may require surgery. This early identification could potentially lead to better outcomes and quality of life for these patients.
At the conclusion of management within the OPSC & MDS several options are possible for patients of the service. These are discharge from both OPSC & MDS and orthopaedic services; or discharge from OPSC & MDS but reinstated/remain on orthopaedic waiting list for review due to the recommendation of the OPSC & MDS musculoskeletal physiotherapist (same or higher category for review) or at the specific request of the patient.
Data
The effectiveness of the OPSC& MDS model was based on a retrospective analysis of the medical records of 980 patients managed at seven Queensland Public Hospitals between July 2008 and June 2010. Table 1 outlines some basic characteristics of the sample.
Probabilities (for example the probability of a person responding to treatment) were calculated where possible from the retrospective review or from internal audit data, other published evidence or expert opinion.
Costs were calculated directly from data obtained in the retrospective review where possible or estimated using hospital audit data, expert opinion and published data. All costs were reported in 2011 Australian Dollars (AU$1 $ US$1).
Health state utilities were calculated from data collected in the retrospective review. Quality of life was measured at baseline and post management (average 24.2 weeks) within the OPSC & MDS service using the Assessment of Quality of Life four dimensions (AQoL-4D), a generic health-related quality of life instrument. 30 The AQoL-4D instrument is a multiattribute utility instrument designed to collect utility values for the purposes of economic evaluations and consists of four separately scored dimensions (independent living, mental health, relationships, senses) based on 12 items developed from other mental health scales and focus groups. The AQoL scoring algorithm combines responses into dimension scores and a single summary utility score appropriate for economic evaluation. 31 Summary scores are anchored between 0 (dead) and 1 (full health). Follow-up utility estimates were calculated for those who responded to treatment (met a clinically important difference on a low back, knee, or shoulder questionnaire) and those who did not respond. These figures were used in the model to represent responders and nonresponders for both OPSC & MDS and Usual Care pathways.
A disutility of 0.001 based on research showing deteriorating quality of life for people on orthopaedic surgical waiting lists 16 was applied after each cycle for those in the 'waiting for appointment' health state.
Utilities were used to derive QALYs used in the denominator of the incremental cost-effectiveness ratio (ICER). The ICER of the OPSC & MDS relative to Usual Care is the additional cost required for one additional QALY. Table 2 summarizes the probabilities, costs and utility values used in the economic model.
Sensitivity analysis
The uncertainty of the model was assessed by one-way and probabilistic sensitivity analysis. In the one-way analysis key cost, probability and utility parameters were tested by altering costs AE30% from baseline and using the 95% confidence intervals for probability and utility values. In addition, the discount rate was altered from 0 to 10%.
Probabilistic sensitivity analysis determines the impact of simultaneously varying all parameters in a model on the ICER, thereby providing an assessment of the level of model uncertainty. All variables in this model were assigned a distribution (using mean (SD) or 95% confidence interval where data were available or by estimating variability in the parameter by AE30% of the mean value). We assumed beta distributions for transition probabilities and utilities and gamma distributions for costs. A second-order Monte Carlo simulation of the model was conducted in Treeage Pro Õ 2013 with 10,000 iterations. This has the effect of running the model 10,000 times, each time randomly sampling from all the distributions of all the variables in the model. The output from this gives 10,000 pairs of results for the OPSC & MDS and Usual Care strategies covering many scenarios possible with the variability of parameters built into the model. The values are plotted on a cost-effectiveness plane with incremental costs on the y axis and incremental QALYs represented on the x axis. Determining cost-effectiveness requires a value of society's or the funder's willingness to pay for a QALY. For this analysis, a threshold value of $50,000 per QALY was chosen. This threshold was determined by considering decisions made in Australia by the Pharmaceutical Benefits Advisory Committee who take into consideration the cost-effectiveness of new medications when making their decisions. This 'revealed preference' indicates that the willingness to pay for a QALY in the early 2000s in Australia was somewhere in the range of $50,000 to $60,000 32 and this figure is supported by a more recent international survey which found a figure of $64,000 per QALY for Australia. 33 
Results
Base case
The OPSC & MDS model is slightly more expensive than Usual Care at an incremental cost of $112; however, also results in a net incremental benefit of 0.23 QALYs resulting in an ICER of $495 ( Table 3 ). The model is sensitive to both the cost of the OPSC & MDS and the probability that it will result in a successful outcome for the patient but not particularly sensitive to changes in other cost estimates, with the highest variation resulting from altering the cost of surgery.
Probabilistic sensitivity analysis
The first 1000 pairs of incremental costs and effects from the Monte Carlo simulation are plotted ( Figure 3 ) on a cost-effectiveness plane. Points in the southeast quadrant represent interventions that are both cost-saving and more effective and hence 'dominate.' Points in the northeast quadrant are more effective than the comparator and also cost more, and hence, a decision must be made on whether it is worth funding these interventions based on society's willingness to pay. At the selected level of $50,000, all points fall below this demonstrating that the OPSC & MDS is cost-effective with a high degree of certainty.
Discussion
The OPSC & MDS is a cost-effective addition to usual orthopaedic care at a willingness to pay threshold of $50,000 per QALY and may even be cost-saving in a number of scenarios. For example, rising costs of surgery over other health care costs would make the OPSC & MDS relatively more cost-effective. This evidence is subject to some uncertainty which is reflected in the probabilistic sensitivity analysis where the 95% credible intervals range from an ICER of $3,466 to a dominant scenario where the OPSC & MDS is both cost-saving and more effective (reported in 37% of simulations). The most frequently occurring scenario was where OPSC & MDS resulted in greater health benefits at additional costs (63% of the simulations). This is the first paper proposing an economic model to compare traditional orthopaedic services in public hospitals to that of a physiotherapist-led service. The model utilized data on the management of three common orthopaedic conditions. Previous economic analyses in orthopaedics have in the main compared different surgical techniques only. Given the increasing cost of managing musculoskeletal conditions that often do not require surgical intervention, models such as the one we used for investigating new services need to be developed. The use of a Markov model and the use of QALYs within that model allows for the effects of waiting times to be incorporated by allowing the use of quality of life decrements for extended waiting. However, the Markov model was limited by a lack of long-term data on patients referred to orthopaedic waiting lists and while a small decrement in quality of life for waiting was assumed, the true impact is unknown and may be higher than the assumption. Many individuals drop out of waiting lists at public hospitals and this may be due to recovery, seeking private treatment, leaving the area or other reasons. However, the long-term outcomes of those who dropped out are not known. The model incorporated categories 2 and 3 patients only as these are the only patients seen by the OPSC & MDS. In order to ensure all benefits are captured, future research should incorporate category 1 patients. The addition of the OPSC & MDS may potentially decrease waiting times for patients with urgent conditions by decreasing overall demand on the orthopaedic system. Additionally, this type of model operates with fixed constraints -for example, all patients are assumed to be able to access services when required, and this assumption may not be realistic in resource-constrained systems. A discrete event simulation model would allow for the incorporation of changing constraints such as numbers of staff and available clinics to model the effect of changing the current service mix provided.
Orthopaedic outpatient hospital services facing waiting list pressures would benefit from the addition of an OPSC & MDS which can stream patients likely to respond to targeted multidisciplinary conservative care in an efficient and timely manner and deliver good outcomes. This ensures faster access to assessment and appropriate treatment options, reduces the time patients wait for review and prevents the associated deterioration in quality of life associated with extended waiting periods. Determining the optimal mix of services that each hospital should provide, however, may require more advanced modelling techniques such as Discrete Event Simulation that can account for changing constraints in the health system. 
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